<DOC>
	<DOC>NCT01421576</DOC>
	<brief_summary>A randomized, open-label, single-dose, crossover clinical trial to evaluate the food effect on the pharmacokinetics of DP-R202 tablet after oral administration in healthy male volunteers.</brief_summary>
	<brief_title>Bioavailability Study of DP-R202 in Healthy Male Volunteers Under Fed Conditions</brief_title>
	<detailed_description>The number of patient is twenty-four.Patients were randomly assigned either DP-R202(Sarpogrelate HCL 300mg, qd) under fasting condition or DP-R202(Sarpogrelate HCL 300mg, qd) after eating foods.</detailed_description>
	<criteria>20 to 55 years of healthy volunteers Hypersensitivity Reaction about Sarpogrelate HCL or other antiplatelets</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2011</verification_date>
</DOC>